Boysen Trine, Christensen Jens K, Madsen Chris D, Eugen-Olsen Jesper, Christensen Laurids S, Møller-Sørensen Helle, Weber Annika, Ladefoged Søren D, Krogsgaard Kim
Clinical Research Unit, Hvidovre University Hospital, Denmark.
Scand J Urol Nephrol. 2003;37(3):259-64. doi: 10.1080/00365590310008163.
To determine the prevalence of TT virus (TTV) in a population of Danish hemodialysis patients and evaluate possible relations between TTV infection and elevated levels of C-reactive protein (CRP) and hypo-response to treatment with erythropoietin (EPO).
Patients on maintenance hemodialysis at a single center were invited to participate. Demographic and clinical data were registered. Blood samples for virological and routine biochemical tests were drawn simultaneously. TTV DNA was detected using polymerase chain reaction (PCR). TTV viral load was estimated by means of semi-quantitative PCR. All patients were tested for hepatitis B, hepatitis C and GB virus C.
Of 252 patients, 204 (80.9%) gave their written informed consent to participate in the study. The prevalence of TTV was 68% and 50% of TTV-positive patients had a high TTV viral load. TTV-positive patients were significantly older than TTV-negative patients (p = 0.011). No relations were found between TTV infection and elevated levels of alanine aminotransferase (ALT) or CRP or hypo-response to EPO treatment. The mean hemoglobin concentration was 11.24 +/- 1.48 g/dl. Patients with a high TTV viral load had a lower level of hemoglobin (10.86 +/- 1.47 g/dl) than the others (p = 0.01). This trend suggested a positive relation between TTV infection and the number of blood transfusions. A restriction fragment length polymorphism assay suggested that patients were infected with different TTV strains.
TTV is common in patients on maintenance hemodialysis. The presence of TTV is associated with increasing age. Patients with a high TTV viral load had lower levels of hemoglobin than the others. TTV infection is not related to elevated levels of ALT or CRP or to hypo-response to EPO treatment.
确定丹麦血液透析患者群体中TTV病毒(TTV)的流行情况,并评估TTV感染与C反应蛋白(CRP)水平升高以及对促红细胞生成素(EPO)治疗反应低下之间的可能关系。
邀请了单中心接受维持性血液透析的患者参与。记录人口统计学和临床数据。同时采集用于病毒学和常规生化检测的血样。使用聚合酶链反应(PCR)检测TTV DNA。通过半定量PCR估算TTV病毒载量。所有患者均接受了乙肝、丙肝和GB病毒C检测。
252例患者中,204例(80.9%)书面知情同意参与研究。TTV的流行率为68%,50%的TTV阳性患者具有高TTV病毒载量。TTV阳性患者显著比TTV阴性患者年龄大(p = 0.011)。未发现TTV感染与丙氨酸转氨酶(ALT)水平升高、CRP升高或对EPO治疗反应低下之间存在关联。平均血红蛋白浓度为11.24±1.48 g/dl。TTV病毒载量高的患者血红蛋白水平(10.86±1.47 g/dl)低于其他患者(p = 0.01)。这一趋势表明TTV感染与输血次数之间存在正相关。限制性片段长度多态性分析表明患者感染了不同的TTV毒株。
TTV在维持性血液透析患者中很常见。TTV的存在与年龄增长相关。TTV病毒载量高的患者血红蛋白水平低于其他患者。TTV感染与ALT或CRP水平升高以及对EPO治疗反应低下无关。